Quoted from http://www.reuters.com/article/2011/01/31/fda-drugs-idUKN3123796920110131
Sanofi, Takeda drugs on FDA early safety probe list
* FDA probing Sanofi heart drug, Takeda diabetes pill
* List does not mean drug causes problem, FDA says
WASHINGTON Jan 31 (Reuters) - U.S. regulators have launched early investigations into potential risks of drugs from Sanofi-Aventis (SASY.PA), Takeda Pharmaceutical Co and other companies, the Food and Drug Administration said on Monday.
The FDA released its quarterly list of investigations into possible drug-safety problems. The newest list covers probes launched between July and September 2010.
Appearing on the list does not mean the FDA has concluded a drug causes the listed problem, the FDA said. The list was posted at bit.ly/eKC2cp .
Among the probes, the agency is reviewing a possible interaction between Sanofi's heart drug Multaq and the bloodthinner warfarin. Takeda's diabetes drug Actos is under review for rhabdomyolysis, a potentially serious type of muscle injury.
Officials at Sanofi and Takeda could not immediately be reached for comment.